Acute Myeloid Leukemia
Dual-specificity fusion toxin selective and potent agent for AML treatment
Published in Cancer Weekly, December 14th, 2004
According to a study from the United States, "Novel agents to treat acute myeloid leukemia (AML) are needed with increased efficacy and specificity.
"We have synthesized a dual-specificity fusion toxin DTU2GMCSF composed of the catalytic and translocation domains of diphtheria toxin (DT) fused to the granulocyte-macrophage colony-stimulating factor (GM-CSF) in which the DT furin cleavage site 163RVRRSV170 is modified to a urokinase plasminogen activator (uPA) cleavage site (163)GSGRSA(170), termed U2."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-12-14)
More Articles from Cancer Weekly
- Breast Cancer
Ultrasound helpful when a woman feels a lump, but clinical exam is normal - Leukemia
CNS abnormalities characterized in pediatric leukemia patients - Ovarian Sex Cord-Stromal Tumor
Loss of heterozygosity at chromosome 19p13.3 indicates gene alteration in SCSTs - Renal Cancer
CD8+ cytotoxic T lymphocytes recognize renal carcinoma antigens - Alzheimer Disease
A novel presenilin 1 mutation (Y154N) discovered in early onset AD - Apoptosis
H2AX phosphorylation at short telomeres in T cells and fibroblasts demonstrated - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
